Marta Guerra Rebollo, PhD
Assistant Professor
+34932672000
RESEARCH LINES
- Development of new hybrid vectors for gene therapy of monogenic diseases (e.j Duchenne Muscular Dystrophy).
- New local RNA delivery systems to increase muscle regeneration.
- Toxicity, biodistribution and treatment efficacy in mouse pre-clinical models.
- mRNA therapeutical Delivery Systems for Targeting Antigen-Presenting Cells, in vitro and in vivo models.
MEMBER OF:
School of Engineering
Materials Engineering
Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.
School of Engineering
Chemical & Synthetic Biology for Biotherapies
This group combines chemistry and synthetic biology to develop precision bio-nano-therapeutics based on smart proteins and to generate molecular systems that enable transport of therapeutics to the brain.
LATEST PROJECTS
LIVENANO (Nuevas nanoterapias industrialmente escalables para tratar la hipertensión portal y la fibrosis hepática en humanos)
Producción a nivel GMP de polímeros terapéuticos y nanopartículas a nivel pre-clínico para tratar patologías hepáticas
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
Duchenne (Recobriment de vectors adenoassosciats per millora de la teràpia gènica)
Teràpia gènica per la distròfia muscular de Duchenne
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
LINKED NEWS
Research
Improving Duchenne Muscular Dystrophy Therapies
18/09/2023
The GEMAT group is working in collaboration with the Duchenne Parent Project Spain association to develop viral vector coating biomaterials to improve gene therapy for the treatment of Duchenne muscular dystrophy.
READ FULL NEW
7 Questions for...
MARTA GUERRA
03/05/2021
Dra. Marta Guerra, miembro del grupo de investigación GEMAT de IQS School of Engineering.
READ FULL NEW
